Luca Bertolaccini Selected Research

Luca Bertolaccini Research Topics

Disease

11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2017
10	Lung Neoplasms (Lung Cancer) 08/2022 - 09/2014
10	Neoplasms (Cancer) 01/2022 - 08/2013
5	Hemorrhage 01/2022 - 02/2012
4	Neoplasm Metastasis (Metastasis) 03/2022 - 12/2014
4	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 09/2014 - 07/2013
3	Fistula 08/2022 - 10/2021
3	Malignant Mesothelioma 03/2019 - 10/2015
3	Postoperative Pain 01/2017 - 03/2016
3	Pneumothorax 05/2015 - 12/2009
2	Lacerations 12/2019 - 04/2012
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2018 - 08/2016
2	Malignant Pleural Effusion 01/2017 - 01/2016
2	Thymoma (Thymic Carcinoma) 12/2014 - 07/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Empyema 01/2022
1	Ventricular Fibrillation 01/2022
1	Lung Diseases (Lung Disease) 02/2020
1	Pneumonia (Pneumonitis) 02/2020
1	Organizing Pneumonia 02/2020
1	Chylothorax 01/2020
1	Pleural Effusion (Pleural Effusions) 01/2020
1	Wounds and Injuries (Trauma) 12/2019
1	Adenocarcinoma of Lung 04/2019
1	Pleural Tuberculosis 03/2019
1	Cardiac Arrhythmias (Arrythmia) 10/2018
1	Solitary Pulmonary Nodule 04/2018
1	Lymphadenopathy 01/2018
1	Lymphadenitis (Adenitis) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Hemothorax 01/2017
1	Asthma (Bronchial Asthma) 08/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 08/2016
1	Gastroesophageal Reflux (GERD) 08/2016
1	Pain (Aches) 03/2016
1	Intraoperative Complications 01/2016
1	Mesothelioma 10/2015
1	Umbilical Hernia (Omphalocele) 07/2015

Drug/Important Bio-Agent (IBA)

3	Biological ProductsIBA 07/2019 - 10/2015
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 04/2014
2	Air Pollutants (Pollutants, Air)IBA 05/2015 - 03/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Methylene Blue (Methylthioninium Chloride)FDA Link 10/2021
1	B7-H1 AntigenIBA 01/2021
1	indolepropanol phosphate (IPP)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Hemostatics (Antihemorrhagics)IBA 12/2019
1	icotinibIBA 04/2019
1	Gefitinib (Iressa)FDA Link 04/2019
1	Cell-Free Nucleic AcidsIBA 04/2019
1	ErbB Receptors (EGF Receptor)IBA 04/2019
1	DNA (Deoxyribonucleic Acid)IBA 04/2019
1	Fluorine-18IBA 04/2018
1	methylamphotericin B (AME)IBA 03/2018
1	SiliconesIBA 01/2018
1	Sclerosing Solutions (Sclerosing Agents)IBA 01/2017
1	Talc FDA Link 01/2017
1	Pepsin A (Pepsin)IBA 08/2016
1	Local AnestheticsIBA 07/2015

Therapy/Procedure

9	Pneumonectomy (Lung Volume Reduction) 08/2022 - 09/2014
5	Radiotherapy 03/2022 - 02/2015
5	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 12/2014
5	Length of Stay 10/2018 - 02/2012
4	Segmental Mastectomy (Lumpectomy) 01/2021 - 06/2017
3	Therapeutics 02/2020 - 10/2015
3	Thoracotomy 12/2019 - 03/2016
2	Immunotherapy 01/2022 - 12/2021
2	Stents 01/2022 - 02/2012
2	Chest Tubes (Chest Tube) 01/2022 - 01/2020
2	Extracorporeal Membrane Oxygenation 01/2021 - 02/2020
2	Ligation 01/2020 - 12/2019
2	Operative Surgical Procedures 03/2019 - 01/2018
2	Operative Time 10/2018 - 02/2012
2	Pleurodesis 01/2017 - 12/2009
2	Transcutaneous Electric Nerve Stimulation (TENS) 09/2014 - 07/2014
1	Drug Therapy (Chemotherapy) 01/2022
1	Left Heart Bypass 01/2022
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Contraindications 01/2022
1	Patient Readmission 01/2022
1	Punctures 02/2021
1	Induction Chemotherapy 01/2021
1	Surgical Instruments (Clip) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 02/2020
1	Lung Transplantation 02/2020
1	Neoadjuvant Therapy 01/2020
1	Conservative Treatment 01/2020
1	Total Parenteral Nutrition 01/2020
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2020
1	Electrocoagulation (Electrocautery) 12/2019
1	Transplantation 10/2018
1	Breast Implants (Breast Implant) 01/2018
1	Mastectomy (Mammectomy) 01/2018
1	Activities of Daily Living (ADL) 03/2016
1	Catheters 01/2016
1	Minimally Invasive Surgical Procedures 01/2016
1	Biological Therapy 10/2015
1	Cytoreduction Surgical Procedures 10/2015
1	Anesthesia 07/2015